These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 23969104

  • 1. A novel polyethylene glycol mediated lipid nanoemulsion as drug delivery carrier for paclitaxel.
    Jing X, Deng L, Gao B, Xiao L, Zhang Y, Ke X, Lian J, Zhao Q, Ma L, Yao J, Chen J.
    Nanomedicine; 2014 Feb; 10(2):371-80. PubMed ID: 23969104
    [Abstract] [Full Text] [Related]

  • 2. An optimized two-vial formulation lipid nanoemulsion of paclitaxel for targeted delivery to tumor.
    Chen L, Chen B, Deng L, Gao B, Zhang Y, Wu C, Yu N, Zhou Q, Yao J, Chen J.
    Int J Pharm; 2017 Dec 20; 534(1-2):308-315. PubMed ID: 28986321
    [Abstract] [Full Text] [Related]

  • 3. Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors.
    Ye J, Liu Y, Xia X, Meng L, Dong W, Wang R, Fu Z, Liu H, Han R.
    Oncol Rep; 2016 Jul 20; 36(1):399-409. PubMed ID: 27175803
    [Abstract] [Full Text] [Related]

  • 4. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L, Zhu D, Dong X, Sun H, Song C, Wang C, Kong D.
    Int J Nanomedicine; 2015 Jul 20; 10():2101-14. PubMed ID: 25844039
    [Abstract] [Full Text] [Related]

  • 5. Porphyrin-lipid stabilized paclitaxel nanoemulsion for combined photodynamic therapy and chemotherapy.
    Chang E, Bu J, Ding L, Lou JWH, Valic MS, Cheng MHY, Rosilio V, Chen J, Zheng G.
    J Nanobiotechnology; 2021 May 25; 19(1):154. PubMed ID: 34034749
    [Abstract] [Full Text] [Related]

  • 6. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P, Wang H, Yu M, Liao Z, Wang X, Zhang F, Ji W, Wu B, Han J, Zhang H, Wang H, Chang J, Niu R.
    Eur J Pharm Biopharm; 2012 Jun 25; 81(2):248-56. PubMed ID: 22446630
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J, Chuan X, Zhang H, Dai W, Wang X, Wang X, Zhang Q.
    Int J Pharm; 2014 Aug 25; 471(1-2):525-35. PubMed ID: 24858391
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
    Chu B, Qu Y, Huang Y, Zhang L, Chen X, Long C, He Y, Ou C, Qian Z.
    Int J Pharm; 2016 Mar 16; 500(1-2):345-59. PubMed ID: 26794876
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
    Lv W, Cheng L, Li B.
    Chem Pharm Bull (Tokyo); 2015 Mar 16; 63(2):68-74. PubMed ID: 25451039
    [Abstract] [Full Text] [Related]

  • 14. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
    Xin H, Chen L, Gu J, Ren X, Wei Z, Luo J, Chen Y, Jiang X, Sha X, Fang X.
    Int J Pharm; 2010 Dec 15; 402(1-2):238-47. PubMed ID: 20934500
    [Abstract] [Full Text] [Related]

  • 15. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
    Huo M, Zhu Q, Wu Q, Yin T, Wang L, Yin L, Zhou J.
    J Pharm Sci; 2015 Jun 15; 104(6):2018-2028. PubMed ID: 25820241
    [Abstract] [Full Text] [Related]

  • 16. Phospholipid-Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel.
    Liang H, Yang Q, Deng L, Lu J, Chen J.
    Drug Dev Ind Pharm; 2011 May 15; 37(5):597-605. PubMed ID: 21469948
    [Abstract] [Full Text] [Related]

  • 17. Immunotherapeutic vitamin E nanoemulsion synergies the antiproliferative activity of paclitaxel in breast cancer cells via modulating Th1 and Th2 immune response.
    Pawar VK, Panchal SB, Singh Y, Meher JG, Sharma K, Singh P, Bora HK, Singh A, Datta D, Chourasia MK.
    J Control Release; 2014 Dec 28; 196():295-306. PubMed ID: 25459427
    [Abstract] [Full Text] [Related]

  • 18. Folic Acid and Poly(ethylene glycol) Decorated Paclitaxel Nanocrystals Exhibit Enhanced Stability and Breast Cancer-Targeting Capability.
    Zhao J, Du J, Wang J, An N, Zhou K, Hu X, Dong Z, Liu Y.
    ACS Appl Mater Interfaces; 2021 Mar 31; 13(12):14577-14586. PubMed ID: 33728919
    [Abstract] [Full Text] [Related]

  • 19. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy.
    Yoshizawa Y, Kono Y, Ogawara K, Kimura T, Higaki K.
    Int J Pharm; 2011 Jun 30; 412(1-2):132-41. PubMed ID: 21507344
    [Abstract] [Full Text] [Related]

  • 20. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
    Wu Y, Chu Q, Tan S, Zhuang X, Bao Y, Wu T, Zhang Z.
    Int J Nanomedicine; 2015 Jun 30; 10():5219-35. PubMed ID: 26316751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.